Systemic mastocytosis associated with acute myeloid leukaemia.
Fong
Catherine
C
Tong
Michael
M
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000378:metabolism; D001854:Bone Marrow Cells / Q000378:metabolism / Q000473:pathology; D002869:Chromosome Aberrations; D003561:Cytarabine / Q000008:administration & dosage; D020732:Cytogenetic Analysis; D005260:Female; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D008407:Mast Cells / Q000378:metabolism / Q000473:pathology*; D034721:Mastocytosis, Systemic / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics
D014408:Biomarkers, Tumor; D003561:Cytarabine; D015255:Idarubicin